Plunkett Research Online: Applied Genetic Technologies Corp

APPLIED GENETIC TECHNOLOGIES CORP (AGTC:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Applied Genetic Technologies is a clinical-stage biotechnology company. The company’s focus is gene therapy through a nontoxic adeno-associated virus.The company also offers gene-therapy-related products such as promoters, expression cassettes, and capsids. AGTC's pipeline portfolio consists of prod.....



Applied Genetic Technologies Corp
Ticker: AGTC
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 386 462-2204
Fax: 386 462-7396
Address: 14193 North West 119th Terrace
Suite 10
Alachua, FL 32615 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
ContactsDescription
Susan WasherCEO/President/Director
William SullivanCFO/Chief Accounting Officer
See More
Applied Genetic Technologies is a clinical-stage biotechnology company. The company’s focus is gene therapy through a nontoxic adeno-associated virus.The company also offers gene-therapy-related products such as promoters, expression cassettes, and capsids. AGTC's pipeline portfolio consists of prod.....See More See More

Auditor: ERNST & YOUNG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: